Associated Papers
OTULIN-Related Autoinflammatory Syndrome With a Novel Mutation Treated With Tumor Necrosis Factor Inhibitor Therapy: A Rare Case Report.
Güngörer V et al.
The Journal of Rheumatology, 2025
Expanding the phenotypic and genetic spectrum of ORAS with novel homozygous variant in OTULIN gene: a case series and literature review.
AlSaleem A et al.
Pediatric Rheumatology Online Journal, 2025
OTULIN-related conditions: Report of a new case and review of the literature using GenIA.
Caballero-Oteyza A et al.
Clinical Immunology (orlando, Fla.), 2024
OTULIN-related conditions: Report of a new case and review of the literature using GenIA.
Caballero-Oteyza A et al.
Research Square, 2024
OTULIN deficiency: focus on innate immune system impairment.
Dou B et al.
Frontiers in Immunology, 2024
Screening of OTULIN gene mutation with targeted next generation sequencing in Turkish populations and in silico analysis of these mutations.
Gezgin Y et al.
Molecular Biology Reports, 2022
Auto-inflammation in a Patient with a Novel Homozygous OTULIN Mutation.
Nabavi M et al.
Journal of Clinical Immunology, 2019
An Update on Autoinflammatory Diseases: Relopathies.
Steiner A et al.
Current Rheumatology Reports, 2018
Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease.
Zhou Q et al.
Proceedings of the National Academy of Sciences of the United States of America, 2016
Select a paper to view details